Abstract
A study was conducted to evaluate repeated intrathecal injections of baclofen, without artificial ventilation, in the treatment of severe tetanus. Ten patients, 5 men and 5 women, with a mean age of 34±7 years, were included in the study. The dose of baclofen injected was 1000 μg between the ages of 16 and 55 years, 800 μg over the age of 55 years and 500 μg under the age of 16 years. The efficacy was assessed on the basis of the resolution of contractures and paroxysms and the initial dose was reinjected prior to the reappearance of these symptoms. Treatment was discontinued in the case of central nervous system depression or inefficacy. The first injection was effective in 9 cases for 24–48 h. The haemodynamic safety was always good. Five patients developed central depression with coma and respiratory depression, requiring artificial ventilation in 3 cases and reversed by flumazenil in 2 cases. Five patients were treated exclusively with baclofen with 4 cures. Five patients had to be ventilated with only one cure. This study confirms earlier studies concerning the efficacy of intrathecal baclofen in tetanus. However, the frequency of episodes of respiratory depression prevents the recommendation of repeated injections when respiratory intensive care facilities are not available.
Similar content being viewed by others
References
Alfery DD, Rauscher LA (1979) Tetanus: a review. Crit Care Med 7:176–181
Edmondson RS, Fowers MW (1979) Intensive care in tetanus: management, complications, and mortality in 100 cases. Br Med J 1:1401–1404
Furste W (1982) Epidemiology of tetanus. Trauma 22:1032–1036
Muller H, Borner U, Zierski J, Hempelmann G (1987) intrathecal 66:76–79
Muller H, Zierski J, Börner U, Hempelmann G (1988) intrathecal baclofen in tetanus. In: Mueller H, Zierski J, Penn RD (eds) Localspinal therapy of spasticity. Springer, Berlin Heidelberg, pp 227–244
Dunlap K (1981) Two types of γ-aminobutyric acid receptors on embryonic sensory neurones. Br J Pharmacol 74:579–585
Demazière J, Saissy JM, Vitris M, Marcoux L, Ndiaye M (1991) Intermittent intrathecal baclofen for severe tetanus (letter) Lancet I:427
Davies J, Tongroach P (1979) Tetanus toxin and synaptic inhibition in the substantia nigra an striatum of rats. J Physiol (Lond) 290:23–36
Brooks VB, Curtis DR, Eccles JC (1957) The action of tetanus toxin on the inhibition of motor neurons. J Physiol (Lond) 135:655–672
Ambache N, Morgan RS, Payling Wright G (1948) The action of tetanus toxin on the rabbit's iris. J Physiol (Lond) 107:45–53
Kerr JH, Corbett JL, Prys-Roberts C, Crampton Smith C, Spalding JMK (1968) Involvement of the sympathetic nervous system in tetanus. Lancet II:236, 241
Wilson PR, Yaksh TL (1978) Baclofen is antinociceptive in the spinal intrathecal space of animals. Eur J Pharmacol 51:323–330
Penn RD, Kroin JS (1985) Continuous intrathecal baclofen for severe spasticity. Lancet II:125–127
Dralle D, Muller H, Zierski J, Klug N (1985) Intrathecal baclofen for spasticity (Letter). Lancet II:1003
Romijn JA, Vanlieshout JJ, Velis DN (1986) Reversible coma due to intrathecal baclofen (Letter). Lancet II:696
Karp P, Wyss E, Mons P, Fauchart JP, Guillaume JL, Favriel JM (1991) Traitement du tétanos par le baclofène intrathécal (Lettre) Réan. Soins intens. Med Urg 7:302
Saissy JM, Raux O, Gohard R, Diatta B (1990) Tetanos severe et baclofene intrathecal. Ann Fr Anesth Reanim 9:183–184
Trujillo MJ, Castillo A, Espana JV, Guevara P, Eganez H (1980) Tetanus in the adult: intensive care and management experience with 233 cases. Crit Care Med 8:419–423
Muller H, Zierski J, Dralle D, Kraub D, Mutschler E (1988) Pharmacokinetics of intrathecal baclofen. In Muller H, Zierski J, Penn RD (eds) Local — Spinal therapy of spasficity. Springer, Berlin Heidelberg, pp 223–226
Penn RD (1988) Chronic intrathecal baclofen for severe rigidity and spasms. In: Muller H, Zierski J, Penn RD (eds) Local-spinal therapy of spasticity. Springer, Berlin Heidelberg, pp 151–153
Yamada KA, Norman WP, Hamosh P, Gillis RA (1982) Medullary ventral surface GABA receptors affect respiratory and cardiovascular function. Brain Res 248:71–78
Muller-Schwete G (1988) Physostigmine reversal of baclofen-induced sedation. In: Muller H, Zierski J, Penn RD (eds) Local-spinal therapy of spasticity. Springer, Berlin Heidelberg, pp 253
Caldwell CB, Cross JB (1982) Physostigmine reversal of midazolam — induced sedation. Anesthesiology 57:125–127
Sawynok J, Dickson C (1985) D-baclofen is an antogonist of baclofen receptors mediating antinociception in the spinal cord. Pharmacology 31:248–259
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Saissy, J.M., Demazière, J., Vitris, M. et al. Treatment of severe tetanus by intrathecal injections of baclofen without artificial ventilation. Intensive Care Med 18, 241–244 (1992). https://doi.org/10.1007/BF01709840
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01709840